{
    "title": "AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11411399/AstraZeneca-Q3-earnings-revenue-beat-estimates.html",
    "date": "2022-11-10",
    "keywords": [
        "china",
        "company",
        "growth",
        "decline",
        "revenue",
        "soriot",
        "ceo",
        "vaccine",
        "covid",
        "application",
        "beat",
        "call",
        "grover",
        "cancer",
        "profit",
        "approval",
        "covid19",
        "companys",
        "year",
        "region",
        "currency",
        "quarter",
        "portfolio",
        "percentage",
        "market",
        "therapy",
        "evusheld",
        "co",
        "street",
        "conference",
        "outlook",
        "thursday",
        "month",
        "business",
        "astrazeneca",
        "bellwether",
        "sector",
        "drug",
        "care",
        "basis",
        "chief",
        "tagrisso",
        "imfinzi",
        "enhertu",
        "oncology",
        "share",
        "forecast",
        "drag",
        "performance",
        "pipeline",
        "story",
        "pharma",
        "note",
        "shot",
        "demand",
        "country",
        "modena",
        "sense",
        "mrna",
        "key",
        "momentum",
        "astrazenecas",
        "portfoliohas",
        "top",
        "uptake",
        "analyst",
        "zhyar",
        "efficacy",
        "couple",
        "version",
        "reporting",
        "editing",
        "jane",
        "merriman",
        "tomasz",
        "janowski",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}